-
19315-5
Se-Aspirin-5 mg
Price: $341.92List Price: $379.91A hybrid of selenium and an NSAID that has been shown to reduce the viability of different cancer cell lines, particularly colorectal cancer (CRC) cells (IC<sub>50</sub> = 3.4 µM) inhibits the cell cycle in G1 and G2/M phases and induces -
-
-
-
S337381-100mg
Sn(IV) Mesoporphyrin IX dichloride (C09-1041-363)
Price: $578.80List Price: $643.11Sn(IV) Mesoporphyrin IX dichloride is a porphyrin derivative that is used in the study of heme degradation. Sn(IV) Mesoporphyrin IX dichloride is a competitive and potent inhibitor of heme oxygenase, known as HO. Sn(IV) Mesoporphyrin IX dichloride -
S337381-1g
Sn(IV) Mesoporphyrin IX dichloride (C09-1041-364)
Price: $4,442.61List Price: $4,936.23Sn(IV) Mesoporphyrin IX dichloride is a porphyrin derivative that is used in the study of heme degradation. Sn(IV) Mesoporphyrin IX dichloride is a competitive and potent inhibitor of heme oxygenase, known as HO. Sn(IV) Mesoporphyrin IX dichloride -
S337381-25mg
Sn(IV) Mesoporphyrin IX dichloride (C09-1041-365)
Price: $307.49List Price: $341.66Sn(IV) Mesoporphyrin IX dichloride is a porphyrin derivative that is used in the study of heme degradation. Sn(IV) Mesoporphyrin IX dichloride is a competitive and potent inhibitor of heme oxygenase, known as HO. Sn(IV) Mesoporphyrin IX dichloride -
15325-10
STO-609 (acetate)-10 mg
Price: $376.35List Price: $418.17A cell-permeable inhibitor of CaMKK&alpha and CaMKK&beta (Ki = 80 and 15 ng/ml, respectively) also blocks autophosphorylation of both isoforms less potently inhibits CaMKII (IC<sub>50</sub> = 10 &mug/ml) and is minimally effective against -
786-1957
Streptavidin, Liquid (C009B-000826)
Price: $237.21List Price: $263.57Streptavidin, Liquid -
786-1958
Streptavidin, Liquid (C009B-000827)
Price: $839.21List Price: $932.46Streptavidin, Liquid -
786-1959
Streptavidin, Liquid (C009B-000828)
Price: $1,770.66List Price: $1,967.40Streptavidin, Liquid -
T647299-1mg
Trachelogenin (C007B-430484)
Price: $544.03List Price: $604.47Trachelogenin ((-)-Trachelogenin) is an HCV entry inhibitor without genotype specificity, and with low cytotoxicity. Trachelogenin inhibits HCVcc infection and HCVpp cell entry in a dose-dependent manner with an IC 50 of 0.325 and 0.259 μg/mL in